PLAY PODCASTS
The Surprising Role of Patient Advocates in Drug Development
Episode 63

The Surprising Role of Patient Advocates in Drug Development

Patient Advocates do more than raise money—they are active participants in the drug development process. While the ALS Ice Bucket Challenge garnered global attention, lesser-known patient advocates also flex their expertise to drive new treatments and cures. In this episode, we talk with two moms, one who is a patient herself, about their work as partners in research and development, helping bring treatments for two rare diseases to the market.

I AM BIO · Susan Ruediger Founder and Chief Mission Officer CMT Research Foundation, Nasha Fitter CEO FOXG1 Research Foundation

October 18, 202220m 55s

Audio is streamed directly from the publisher (chtbl.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Patient Advocates do more than raise money—they are active participants in the drug development process. While the ALS Ice Bucket Challenge garnered global attention, lesser-known patient advocates also flex their expertise to drive new treatments and cures.  In this episode, we talk with two moms, one who is a patient herself, about their work as partners in research and development, helping bring treatments for two rare diseases to the market. 

Susan Ruediger, Founder and Chief Mission Officer, CMT Research Foundation  

Nasha Fitter, CEO, FOXG1 Research Foundation  
 

Topics

patient advocacysusan ruedigernatural history studyfoxg1nasha fittercurespatient advocatesbiopharmaceuticalsdrug fundingfoxg1 research foundationi am bio podcastdrug developmenttreatmentsresearch and developmentclinical trialscmtrare diseasecmt research foundationbiotechnolobyice bucket challengealsbio one-on-one partnering